<DOC>
	<DOCNO>NCT02068430</DOCNO>
	<brief_summary>This study evaluate Safety Effectiveness UV-X System Corneal Collagen Cross-Linking Eyes Corneal Infection . The treatment UV-X system use eyedrops riboflavin , also know vitamin B2 , ultraviolet A ( UVA ) light . The eye drop place affected eye affect cornea expose UVA . UVA/riboflavin corneal collagen cross-linking first use treat patient 1998 Dresden , Germany . Data date obtain mostly physicians outside United States strongly suggest treatment acceptable alternative , many subject last effect ( progression ) 3-5 year initial treatment .</brief_summary>
	<brief_title>Safety Effectiveness UV-X System Corneal Collagen Cross-Linking Eyes With Refractory Corneal Infection</brief_title>
	<detailed_description>This study design evaluate safety effectiveness use UV-X™ system treat corneal ulcer proven refractory conventional antibiotic treatment . The UV-X™ system combination product consist UVA 365 nm wavelength light source ( UV-X™ Illumination System ) riboflavin ( Medio-Cross® Riboflavin 0.1 % ) ophthalmic solution . The therapeutic effect mediate photochemical interaction ultraviolet ( UV ) light riboflavin saturate infected corneal stromal tissue . The photochemical interaction UVA light riboflavin use sterilize pathogen blood blood product . Pathogens include virus , bacteria , fungi , protozoa show sterilized use photochemical process . Presumably singlet oxygen produce interaction UVA riboflavin . It singlet oxygen interact pathogen 's Deoxyribonucleic acid ( DNA ) sufficiently disruptive manner render expose field sterile . The cross-linking improves mechanical property anterior stroma show stabilize corneal structure patient progressive keratoconus ectasias follow refractive surgery . The technology apply handful patient corneal ulcer single small series bullous keratopathy . In case patient worsen treatment . In majority case , considerable clinical reversal deteriorate clinical course obtain . There debate mechanism action beneficial effect . It speculate proteolytic collagenase enzyme destroy photochemical process . As alternate , suggest corneal collagen strengthen cross link becomes resistant infectious process . Finally direct sterilization effect UVA light , riboflavin , combination postulate . Recent laboratory work show staphylococci culture agar plate kill expose combination UVA riboflavin use experiment . Neither UVA riboflavin alone bactericidal effect . The procedure use investigator propose study treat corneal infection ulceration identical procedure use strengthen cornea . It perform saturate cornea riboflavin 0.1 % riboflavin solution expose riboflavin soak cornea UVA light . After corneal stroma saturation achieve , infected tissue expose UVA light 365 nm irradiance 3 mW/cm2 30 minute . Exposure cornea combination UVA light ( 365 nm ; 3 mW/cm2 irradiation ; 30 minute duration ) topical administration riboflavin appear broad sterilization effect base photochemical interaction UVA riboflavin .</detailed_description>
	<mesh_term>Corneal Ulcer</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects one eye meet follow criterion : 18 year age old Having diagnosis corneal ulcer . Corneal scrap send culture sensitivity . Having treat least three day conventional broad spectrum anti infective therapy without improvement Showing response therapy one follow criterion : Progressive thin cornea Increasing diameter corneal ulcer Increasing diameter corneal infiltrate Persistent epithelial defect Persistent inflammatory sign iritis hypopyon Persistent pain All subject meet follow criterion exclude study : A corneal ulcer perforate A corneal ulcer produce descemetocele . Women may breastfeed pregnant woman . Herpetic infection suggest history clinical evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Corneal Ulcers</keyword>
	<keyword>cross-linking</keyword>
	<keyword>UVA</keyword>
	<keyword>Riboflavin</keyword>
</DOC>